These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36375982)

  • 1. Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives.
    Zhao S; Cheng Y; Tong X; Han M; Ji L; Che Y; Hu W; Liu A
    BMJ Open; 2022 Nov; 12(11):e065133. PubMed ID: 36375982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours.
    Chen J; Liang X; Tong X; Han M; Ji L; Zhao S; Hu Z; Liu A
    J Neurointerv Surg; 2023 Jan; 15(1):46-51. PubMed ID: 35074896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM; Guzauskas GF; Chen E; Lalla D; Tayama D; Fagan SC; Veenstra DL
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
    Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
    PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.
    Ni W; Kunz WG; Goyal M; Ng YL; Tan K; De Silva DA
    BMJ Open; 2020 Sep; 10(9):e036517. PubMed ID: 32948553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke.
    Qureshi AI; Akinci Y; Huang W; Ishfaq MF; Hassan AE; Siddiq F; Gomez CR
    J Neurosurg; 2023 Jan; 138(1):223-232. PubMed ID: 35901768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Magnetic Resonance Imaging-Guided Thrombolysis for Patients With Stroke With Unknown Time of Onset.
    Muntendorf LK; Konnopka A; König HH; Boutitie F; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
    Value Health; 2021 Nov; 24(11):1620-1627. PubMed ID: 34711362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran.
    Amiri A; Goudarzi R; Amiresmaili M; Iranmanesh F
    J Med Econ; 2018 Mar; 21(3):282-287. PubMed ID: 29105528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of mechanical thrombectomy within 6 hours of acute ischaemic stroke in China.
    Pan Y; Cai X; Huo X; Zhao X; Liu L; Wang Y; Miao Z; Wang Y
    BMJ Open; 2018 Feb; 8(2):e018951. PubMed ID: 29472264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
    Leppert MH; Campbell JD; Simpson JR; Burke JF
    Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.
    Joo H; Wang G; George MG
    Am J Prev Med; 2017 Dec; 53(6S2):S205-S212. PubMed ID: 29153122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.
    Boudreau DM; Guzauskas G; Villa KF; Fagan SC; Veenstra DL
    Ann Emerg Med; 2013 Jan; 61(1):46-55. PubMed ID: 22633340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study.
    Han M; Qin Y; Tong X; Ji L; Zhao S; Liu L; Chen J; Liu A
    BMJ Open; 2022 Apr; 12(4):e059098. PubMed ID: 35387833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand.
    Rattanavipapong W; Worakijthamrongchai T; Soboon B; Luankongsomchit V; Kongmuangpuk M; Isaranuwatchai W; Teerawattananon Y; Nilanont Y
    BMJ Open; 2022 Sep; 12(9):e064403. PubMed ID: 36167373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.
    Wang L; Zeng Y; Zhou L; Xu P; Guo X; Xie Y; Cai J; Pan M; Tang J; Gong Q; Su R; Liu Y; Lou Y
    PLoS One; 2024; 19(2):e0297939. PubMed ID: 38363737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.